Hillhurst Biopharmaceuticals, Inc. SBIR Phase I Award, April 2018
A SBIR Phase I contract was awarded to Hillhurst Biopharmaceuticals, Inc. in April, 2018 for $224,940.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Name
# Contributions
Last Contribution
Find more entities like Hillhurst Biopharmaceuticals, Inc. SBIR Phase I Award, April 2018
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.